Tuesday, Feb. 15, 2022, 12 p.m.-1 p.m. ET What were the most surprising aspects of health policy and regulation during the first year of the Biden administration? And what lies ahead for the second year, given the key players, the continuing pandemic, a tightly-divided Congress, and midterm elections that may flip control in one or (more…)
Friday, Jan. 21, 2022, 12-1 pm ET (revised date) Nearly a year into the Biden administration, Dr. Robert Califf has been nominated to return as FDA Commissioner – amidst a continuing pandemic and criticism of recent FDA decisions and messaging. What’s next for the FDA under Dr. Califf’s leadership? Join us for the insights of (more…)
Friday, June 4, 2021, 12-1 pm ET What happens at the FDA is central to all health marketing and communications, controlling the flow of new drug approvals and regulating what manufacturers may say about their products. The agency has been through unprecedented challenges over the past two years. Now, with a new president and new (more…)
May 12, 2021, 12-1 pm ET Concern is building in Washington over misuse of personal data and risks to privacy. Meanwhile, Virginia just followed California in enacting comprehensive data privacy regulation, and other states are considering their own laws, forcing businesses to deal with different rules in different states. What do we need to know (more…)
Dec. 16, 2020, 12-1 pm ET The FDA entered 2020 with a new Commissioner, then soon faced unusual scientific challenges—and unprecedented political attacks—as it worked to cope with the COVID-19 pandemic. Yet, even as its credibility took some hits, the FDA has moved forward aggressively to establish a streamlined process for evaluating COVID-19 vaccines and (more…)
Nov. 19, 2020, 12-1 pm ET It has been a bitterly contested 2020 election season, headlined by the COVID-19 pandemic, a steep recession, and a dizzying array of surprises. When the votes are in, what will it all mean? Join us for an expert assessment by Kate Rawson, senior editor of Prevision Policy. She’ll (more…)
Whichever party wins the White House and control of the Senate and House, issues important to the health marketing and communication community are going to be front and center in Washington in 2021. Who will be the key players in the new administration, HHS, FDA, CMS, and key committees in Congress? And what will be (more…)